Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Absolute risk trade-offs of donor age, sex, and graft source in PTCy-based transplantation.
Journal: Blood advances
Published: March 09, 2026
Absolute Risk Trade-offs of Donor Age, Sex, and Graft Source in PTCy-Based Transplantation.
Journal: Blood advances
Published: March 09, 2026
Haploidentical versus matched unrelated donor transplantation with post-transplant cyclophosphamide: a platform-dependent machine learning analysis of donor age.
Journal: Leukemia
Published: November 12, 2025
Challenging a clinical dogma with multimodal machine learning: a retrospective analysis of transplant mismatched donor selection.
Journal: Leukemia
Published: October 28, 2025
Remission of TP53-Mutant AML After Transplantation With Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Followed by a Donor-Derived Anti-CD33 Chimeric Antigen Receptor T (VCAR33).
Journal: JCO precision oncology
Published: October 23, 2025
CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trial.
Journal: Nature medicine
Published: August 01, 2025
CCRL2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53.
Journal: bioRxiv : the preprint server for biology
Published: March 10, 2025
C-C motif chemokine receptor-like 2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53.
Journal: Haematologica
Published: March 04, 2025
CD8+ T-cell differentiation and dysfunction inform treatment response in acute myeloid leukemia.
Journal: Blood
Published: June 30, 2023
Last Updated: 09/26/2026